First Time Loading...

Hologic Inc
NASDAQ:HOLX

Watchlist Manager
Hologic Inc Logo
Hologic Inc
NASDAQ:HOLX
Watchlist
Price: 75.98 USD 0.36% Market Closed
Updated: Apr 27, 2024
Section:
 

Relative Value

The Relative Value of one HOLX stock under the Base Case scenario is 65.46 USD. Compared to the current market price of 75.98 USD, Hologic Inc is Overvalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HOLX Relative Value
Base Case
65.46 USD
Overvaluation 14%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.5
P/S
P/S
Price to Sales
4.5
vs History
23
vs Industry
29
Median 3Y
3.8
Median 5Y
4
Industry
2.4
Forward
4.3
More Details
34.6
P/E
P/E
Price to Earnings
34.6
vs History
17
vs Industry
16
Median 3Y
13.9
Median 5Y
14.1
Industry
23.2
Forward
18.5
More Details
17.5
P/OCF
P/OCF
Price to OCF
17.5
vs History
42
vs Industry
24
Median 3Y
9
Median 5Y
16.5
Industry
15.5
More Details
30.5
P/FCFE
P/FCFE
Price to FCFE
30.5
vs History
19
vs Industry
19
Median 3Y
11.7
Median 5Y
20.7
Industry
23.5
More Details
3.8
P/B
P/B
Price to Book Value
3.8
vs History
71
vs Industry
23
Median 3Y
3.8
Median 5Y
4.4
Industry
2.2
More Details
4.6
EV/S
EV/S
Enterprise Value to Sales
4.6
vs History
36
vs Industry
26
Median 3Y
3.9
Median 5Y
4.5
Industry
2.5
Forward
4.5
More Details
8.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.4
vs History
39
vs Industry
28
Median 3Y
6.2
Median 5Y
7.9
Industry
5.2
More Details
15
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
15
vs History
26
vs Industry
24
Median 3Y
9
Median 5Y
13.1
Industry
12.5
Forward
13.8
More Details
20.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.4
vs History
36
vs Industry
23
Median 3Y
11.1
Median 5Y
17.3
Industry
17.2
Forward
15.4
More Details
18.1
EV/OCF
EV/OCF
Enterprise Value to OCF
18.1
vs History
44
vs Industry
25
Median 3Y
10
Median 5Y
17.1
Industry
15.1
More Details
21.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
21.5
vs History
44
vs Industry
23
Median 3Y
11.1
Median 5Y
20.2
Industry
19.7
More Details
2.9
EV/IC
EV/IC
Enterprise Value to IC
2.9
vs History
30
vs Industry
28
Median 3Y
2.8
Median 5Y
2.7
Industry
2
More Details

Multiples Across Competitors

HOLX Competitors Multiples
Hologic Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Hologic Inc
NASDAQ:HOLX
17.8B USD 4.5 34.6 15 20.4
US
Abbott Laboratories
NYSE:ABT
186.5B USD 4.6 33.1 19.5 29
US
Intuitive Surgical Inc
NASDAQ:ISRG
133.1B USD 18.2 67 54.9 68.9
US
Stryker Corp
NYSE:SYK
127.6B USD 6.2 40.3 25.1 31.1
US
Boston Scientific Corp
NYSE:BSX
107.2B USD 7.5 68.3 31.7 47.3
IE
Medtronic PLC
NYSE:MDT
106B USD 3.3 25.2 13.5 19.1
US
Becton Dickinson and Co
NYSE:BDX
66.9B USD 3.4 54.9 18.4 38.9
DE
Siemens Healthineers AG
XETRA:SHL
59.1B EUR 2.7 38.9 18.6 31.4
US
Edwards Lifesciences Corp
NYSE:EW
52B USD 8.7 37 26.8 29
US
Dexcom Inc
NASDAQ:DXCM
47.9B USD 13.2 88.5 59.6 77.6
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
349.3B CNY 10.2 30.8 26.7 26.7

See Also

Summary
HOLX intrinsic value, competitors valuation, and company profile.
DCF Valuation
HOLX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HOLX stock valuation using valuation multiples.
Wall Street Estimates
HOLX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HOLX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.